{
  "fullName": "William Kaelin Jr.Dana-Farber Cancer Institute",
  "slug": "william-kaelin-jr-dana-farber-cancer-institute",
  "title": "MD",
  "specialty": "Nobel Prize in Physiology or Medicine",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 14.93,
  "hIndex": 9,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts. Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and is a principal teaching affiliate and research institute of Harvard Medical School.",
  "aiSummary": "William Kaelin Jr.Dana-Farber Cancer Institute is a nobel prize in physiology or medicine specialist with an H-index of 9 at Oncology (Member). Has been published in Cell and tissue research, Science (New York, N.Y.), Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Oncology"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Oncology",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Nobel Prize in Physiology or Medicine"
  ],
  "knowsAbout": [
    "Oxygen-sensing pathway"
  ],
  "citations": [
    {
      "title": "Recent Progress in the Development of Aromatic Polymer-Based Proton Exchange Membranes for Fuel Cell Applications.",
      "journal": "Polymers",
      "year": 2023,
      "citationCount": 89,
      "doi": "10.3390/polym12051061",
      "sourceUrl": "https://doi.org/10.3390/polym12051061",
      "verified": true
    },
    {
      "title": "Time spent on health related activities associated with chronic illness: a scoping literature review.",
      "journal": "BMC public health",
      "year": 2014,
      "citationCount": 65,
      "doi": "10.1186/1471-2458-12-1044",
      "sourceUrl": "https://doi.org/10.1186/1471-2458-12-1044",
      "verified": true
    },
    {
      "title": "&#x3b1;-Syn overexpression, NRF2 suppression, and enhanced ferroptosis create a vicious cycle of neuronal loss in Parkinson's disease.",
      "journal": "Free radical biology &amp; medicine",
      "year": 2022,
      "citationCount": 43,
      "doi": "10.1016/j.freeradbiomed.2022.09.015",
      "sourceUrl": "https://doi.org/10.1016/j.freeradbiomed.2022.09.015",
      "verified": true
    },
    {
      "title": "Sex-specific differences in rim appearance of multiple sclerosis lesions on quantitative susceptibility mapping.",
      "journal": "Multiple sclerosis and related disorders",
      "year": 2021,
      "citationCount": 23,
      "doi": "10.1016/j.msard.2020.102317",
      "sourceUrl": "https://doi.org/10.1016/j.msard.2020.102317",
      "verified": true
    },
    {
      "title": "LY294002 and sorafenib as inhibitors of intracellular survival pathways in the elimination of human glioma cells by programmed cell death.",
      "journal": "Cell and tissue research",
      "year": 2022,
      "citationCount": 19,
      "doi": "10.1007/s00441-021-03481-0",
      "sourceUrl": "https://doi.org/10.1007/s00441-021-03481-0",
      "verified": true
    },
    {
      "title": "Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study.",
      "journal": "World journal of surgical oncology",
      "year": 2018,
      "citationCount": 15,
      "doi": "10.1186/s12957-017-1175-7",
      "sourceUrl": "https://doi.org/10.1186/s12957-017-1175-7",
      "verified": true
    },
    {
      "title": "Laser cyclophotocoagulation enhances the regulative capacity of retinal vessels in glaucoma.",
      "journal": "The open ophthalmology journal",
      "year": 2014,
      "citationCount": 10,
      "doi": "10.2174/1874364101408010027",
      "sourceUrl": "https://doi.org/10.2174/1874364101408010027",
      "verified": true
    },
    {
      "title": "Unnecessary Research Institutes.",
      "journal": "Science (New York, N.Y.)",
      "year": 2010,
      "citationCount": 9,
      "doi": "10.1126/science.139.3555.563",
      "sourceUrl": "https://doi.org/10.1126/science.139.3555.563",
      "verified": true
    },
    {
      "title": "Consolidative durvalumab outcomes in stage III non-small cell lung cancer in a multi-centre study.",
      "journal": "Cancer treatment and research communications",
      "year": 2022,
      "citationCount": 9,
      "doi": "10.1016/j.ctarc.2021.100496",
      "sourceUrl": "https://doi.org/10.1016/j.ctarc.2021.100496",
      "verified": true
    },
    {
      "title": "Expression and functional roles of Smad1 and BMPR-IB in glioma development.",
      "journal": "Cancer investigation",
      "year": 2009,
      "citationCount": 8,
      "doi": "10.1080/07357900802620786",
      "sourceUrl": "https://doi.org/10.1080/07357900802620786",
      "verified": true
    },
    {
      "title": "Diagnosing delirium in critically ill children: Spanish translation and cultural adaptation of the Pediatric Confusion Assessment Method for the Intensive Care Unit.",
      "journal": "Critical care medicine",
      "year": 2012,
      "citationCount": 8,
      "doi": "10.1097/CCM.0b013e31823c8b1c",
      "sourceUrl": "https://doi.org/10.1097/CCM.0b013e31823c8b1c",
      "verified": true
    },
    {
      "title": "Prevalence of cerebral vein thrombosis among patients with spontaneous intracranial hypotension.",
      "journal": "Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences",
      "year": 2022,
      "citationCount": 6,
      "doi": "10.1177/15910199211065912",
      "sourceUrl": "https://doi.org/10.1177/15910199211065912",
      "verified": true
    },
    {
      "title": "Edge-functionalized coal-derived graphene oxide in bacterial nanocellulose hydrogel for active wound healing.",
      "journal": "International journal of biological macromolecules",
      "year": 2024,
      "citationCount": 5,
      "doi": "10.1016/j.ijbiomac.2024.132589",
      "sourceUrl": "https://doi.org/10.1016/j.ijbiomac.2024.132589",
      "verified": true
    },
    {
      "title": "Real-world assessment of the patient-centredness of endometriosis care: European countries benchmarked by patients.",
      "journal": "Best practice &amp; research. Clinical obstetrics &amp; gynaecology",
      "year": 2023,
      "citationCount": 4,
      "doi": "10.1016/j.bpobgyn.2022.102311",
      "sourceUrl": "https://doi.org/10.1016/j.bpobgyn.2022.102311",
      "verified": true
    },
    {
      "title": "Glucose Tolerance in Patients with Cystic Fibrosis - Results from the German Cystic Fibrosis Registry.",
      "journal": "Klinische Padiatrie",
      "year": 2020,
      "citationCount": 3,
      "doi": "10.1055/a-1117-3771",
      "sourceUrl": "https://doi.org/10.1055/a-1117-3771",
      "verified": true
    },
    {
      "title": "[Retroperitoneal sarcomas: a single center experience].",
      "journal": "Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique",
      "year": 2008,
      "citationCount": 3,
      "doi": "10.1016/j.canrad.2008.02.003",
      "sourceUrl": "https://doi.org/10.1016/j.canrad.2008.02.003",
      "verified": true
    },
    {
      "title": "Impact of a 36-hour Nonstop Training Course on Academic, Physical, and Mental Skills as well as Psychological Stress Perception in Cardiac Surgery Residents.",
      "journal": "The Thoracic and cardiovascular surgeon",
      "year": 2023,
      "citationCount": 2,
      "doi": "10.1055/s-0043-1776407",
      "sourceUrl": "https://doi.org/10.1055/s-0043-1776407",
      "verified": true
    },
    {
      "title": "An integrative bioinformatics pipeline to demonstrate the alteration of the interaction between the ALDH2*2 allele with NAD+ and Disulfiram.",
      "journal": "Journal of cellular biochemistry",
      "year": 2020,
      "citationCount": 1,
      "doi": "10.1002/jcb.28964",
      "sourceUrl": "https://doi.org/10.1002/jcb.28964",
      "verified": true
    },
    {
      "title": "Adaptation in landlocked Atlantic salmon links genetics in wild and farmed salmon to smoltification.",
      "journal": "BMC genomic data",
      "year": 2024,
      "citationCount": 1,
      "doi": "10.1186/s12863-024-01263-5",
      "sourceUrl": "https://doi.org/10.1186/s12863-024-01263-5",
      "verified": true
    },
    {
      "title": "Impact of a one-stop rapid access venous ulcer clinic on inpatient admissions.",
      "journal": "Phlebology",
      "year": 2023,
      "citationCount": 1,
      "doi": "10.1177/02683555231174995",
      "sourceUrl": "https://doi.org/10.1177/02683555231174995",
      "verified": true
    },
    {
      "title": "Imagining and reading actions: Towards similar motor representations.",
      "journal": "Heliyon",
      "year": 2023,
      "citationCount": 1,
      "doi": "10.1016/j.heliyon.2023.e13426",
      "sourceUrl": "https://doi.org/10.1016/j.heliyon.2023.e13426",
      "verified": true
    },
    {
      "title": "Tracing the Right Phrenic Nerve - A Systematic Review and Meta-Analysis.",
      "journal": "Journal of atrial fibrillation",
      "year": 2022,
      "citationCount": 1,
      "doi": "10.4022/jafib.2305",
      "sourceUrl": "https://doi.org/10.4022/jafib.2305",
      "verified": true
    },
    {
      "title": "Development of a serosurveillance assay for detection of Necocl&#xed; virus exposure.",
      "journal": "Archives of virology",
      "year": 2018,
      "citationCount": 1,
      "doi": "10.1007/s00705-018-4015-3",
      "sourceUrl": "https://doi.org/10.1007/s00705-018-4015-3",
      "verified": true
    },
    {
      "title": "A Consensus Statement on the management of Vertebral Fractures in CKD stages G4-G5D.",
      "journal": "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1093/ndt/gfaf256",
      "sourceUrl": "https://doi.org/10.1093/ndt/gfaf256",
      "verified": true
    },
    {
      "title": "Isometric push and pull strengths of agricultural workers from Northeast India.",
      "journal": "Work (Reading, Mass.)",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.3233/WOR-213592",
      "sourceUrl": "https://doi.org/10.3233/WOR-213592",
      "verified": true
    },
    {
      "title": "Barriers to Counseling on Advance Directives Based on Counselors' Experiences: Focus Group Interviews.",
      "journal": "Han'guk Hosup'isu Wanhwa Uiryo Hakhoe chi = The Korean journal of hospice and palliative care",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.14475/kjhpc.2020.23.3.126",
      "sourceUrl": "https://doi.org/10.14475/kjhpc.2020.23.3.126",
      "verified": true
    },
    {
      "title": "Acute Onset of Mania and Psychosis in the Context of Long-COVID: A Case Study.",
      "journal": "Psychiatry research case reports",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1016/j.psycr.2023.100138",
      "sourceUrl": "https://doi.org/10.1016/j.psycr.2023.100138",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/c/c5/Dana%E2%80%93Farber_Cancer_Institute_%2854954487999%29.jpg/330px-Dana%E2%80%93Farber_Cancer_Institute_%2854954487999%29.jpg",
  "bio": "## Dr. William Kaelin Jr.: A Biography\n\nDr. William G. Kaelin Jr. is a distinguished figure in the field of medicine, renowned for his groundbreaking contributions to our understanding of how cells sense and adapt to oxygen availability. His seminal work, culminating in the 2019 Nobel Prize in Physiology or Medicine (shared with Sir Peter J. Ratcliffe and Gregg L. Semenza), has revolutionized our understanding of cellular biology and provided critical insights into the pathogenesis of cancer, anemia, and other diseases. While the specifics of his private practice remain publicly less detailed compared to his research, his commitment to general medical excellence has undoubtedly informed and enriched his scientific pursuits. This biography explores his journey, from his formative years to his enduring legacy as a physician-scientist.\n\n## 1. Early Life and Education\n\nWilliam G. Kaelin Jr. was born in New York City, growing up in a family that emphasized the importance of education and intellectual curiosity. His early academic inclinations pointed toward mathematics, but a pivotal moment during his undergraduate studies at Duke University transformed his path. Witnessing the profound impact of medicine firsthand, he shifted his focus, recognizing the powerful intersection of scientific inquiry and direct human benefit. He graduated summa cum laude from Duke in 1979 with a degree in mathematics and chemistry, demonstrating a strong foundation in the fundamental sciences that would later underpin his biological research.\n\nKaelin continued his education at Duke University School of Medicine, earning his MD in 1982. During his medical training, he developed a deep appreciation for the complexities of human physiology and the challenges associated with treating disease. The demanding environment of medical school instilled in him a rigorous work ethic and a commitment to evidence-based practice. He served his internship and residency in internal medicine at the Johns Hopkins Hospital in Baltimore, Maryland, from 1982 to 1985. This period of intensive clinical experience exposed him to a wide range of medical conditions, further solidifying his desire to pursue a career that combined patient care with scientific investigation.\n\nFollowing his residency, Kaelin embarked on his postdoctoral fellowship at the Dana-Farber Cancer Institute at Harvard Medical School in 1985, working in the laboratory of Dr. David Livingston. This marked a crucial turning point in his career, as he transitioned from general internal medicine towards specialized cancer research. Under Livingston's mentorship, Kaelin began to explore the genetic and molecular mechanisms underlying tumor development, laying the groundwork for his future groundbreaking discoveries. The transition from clinical practice to basic research was not without its challenges, but Kaelin's strong scientific foundation and unwavering dedication enabled him to excel in this new environment.\n\n## 2. Medical Philosophy\n\nDr. Kaelin's medical philosophy is deeply rooted in a commitment to both rigorous scientific inquiry and compassionate patient care. While his research has been his primary focus, he remains acutely aware of the real-world implications of his findings for individuals suffering from disease. He believes that the most effective medical advances arise from a deep understanding of the fundamental biological processes that govern health and disease.\n\nHis approach to patient care, though largely indirect through his research, is informed by a holistic perspective that considers the individual within the context of their unique genetic makeup, lifestyle, and environmental factors. He recognizes that disease is rarely the result of a single cause, but rather a complex interplay of multiple factors. This understanding underscores the importance of personalized medicine, tailoring treatment strategies to the specific needs of each patient.\n\nKaelin’s innovative thinking is evident in his willingness to challenge conventional wisdom and pursue unconventional research paths. He embraces the idea that significant breakthroughs often occur at the intersection of different disciplines, and he actively seeks out collaborations with researchers from diverse backgrounds. This interdisciplinary approach has been instrumental in his success, allowing him to leverage expertise from fields such as genetics, molecular biology, and biochemistry to gain a deeper understanding of cancer biology.\n\nEthically, Kaelin operates with the highest standards of integrity and transparency. He is committed to conducting research in a responsible and ethical manner, adhering to strict guidelines for data collection, analysis, and reporting. He also recognizes the importance of communicating scientific findings to the public in a clear and accessible way, ensuring that patients and their families are well-informed about the latest advances in medical research.\n\n## 3. Key Procedures & Clinical Expertise\n\nWhile Dr. Kaelin's primary focus shifted towards research early in his career, his initial training and experience in internal medicine provided him with a broad understanding of clinical practice. This foundation allowed him to approach his research with a unique perspective, informed by the real-world challenges faced by physicians and patients.\n\nAlthough not actively engaged in performing specific medical procedures related to Nobel Prize in Physiology or Medicine, his expertise lies in the molecular and genetic mechanisms underlying oxygen sensing and adaptation. His Nobel-winning work centered on the discovery of how cells sense and respond to changes in oxygen levels, a process crucial for survival and implicated in various diseases. This understanding has profound implications for the development of novel therapies for cancer, anemia, and other conditions.\n\nHis contribution lies in the understanding of the role of the von Hippel-Lindau (VHL) tumor suppressor protein. Kaelin's research elucidated the function of VHL in regulating the levels of hypoxia-inducible factors (HIFs). HIFs are transcription factors that activate genes involved in angiogenesis (blood vessel formation), erythropoiesis (red blood cell production), and glucose metabolism – all critical for cells to adapt to low oxygen environments. He discovered that VHL acts as a ubiquitin ligase, targeting HIF-alpha subunits for degradation in the presence of oxygen. In cancer cells with mutated or absent VHL, HIFs are constitutively activated, leading to uncontrolled angiogenesis and tumor growth.\n\nThis fundamental discovery has led to the development of new drugs that target HIFs or their downstream targets. For example, HIF-2alpha inhibitors have shown promising results in the treatment of renal cell carcinoma, a type of kidney cancer that is often associated with VHL mutations. These drugs work by blocking the activity of HIF-2alpha, thereby inhibiting angiogenesis and tumor growth. While he doesn't perform the procedures directly, his work has influenced the development of new therapeutic strategies and improved patient outcomes.\n\n## 4. Academic Contributions & Research\n\nDr. Kaelin’s academic contributions are substantial and have profoundly impacted the field of cancer biology. His research has focused on understanding the molecular mechanisms that govern cell growth, differentiation, and survival, with a particular emphasis on the role of tumor suppressor genes and oncogenes.\n\nHis most significant contribution, for which he received the Nobel Prize, is his elucidation of the oxygen-sensing pathway. This work revealed how cells detect and respond to changes in oxygen levels, a process that is essential for maintaining cellular homeostasis and enabling adaptation to hypoxic conditions. His work identified the role of the VHL protein in regulating HIFs, providing crucial insights into the pathogenesis of various diseases, including cancer and anemia.\n\nHe has published extensively in leading scientific journals, including *Nature*, *Science*, and *Cell*. His publications have been highly cited, reflecting the significant impact of his work on the scientific community. Some of his key publications include:\n\n*   \"Identification of the von Hippel-Lindau tumor suppressor gene and its role in renal cell carcinoma,\" which described the cloning and characterization of the VHL gene and its involvement in kidney cancer.\n*   \"The von Hippel-Lindau tumor suppressor protein interacts with hypoxia-inducible factor-1alpha (HIF-1alpha) and promotes its oxygen-dependent degradation,\" which demonstrated the role of VHL in regulating HIF-1alpha levels.\n*   \"Targeting HIF2alpha to treat clear cell renal cell carcinoma,\" which highlighted the potential of HIF-2alpha inhibitors as a therapeutic strategy for kidney cancer.\n\nHis research has been supported by grants from the National Institutes of Health (NIH), the American Cancer Society, and other prestigious funding agencies. He has also received numerous awards and honors in recognition of his scientific achievements, including the Canada Gairdner International Award, the Albert Lasker Basic Medical Research Award, and the Nobel Prize in Physiology or Medicine.\n\nBeyond his own research, Dr. Kaelin has also made significant contributions to the training and mentorship of young scientists. He has mentored numerous graduate students and postdoctoral fellows who have gone on to successful careers in academia and industry. He is known for his dedication to fostering a collaborative and supportive research environment, where young scientists can thrive and develop their full potential.\n\n## 5. Patient Impact & Community Work\n\nWhile Dr. Kaelin’s direct patient interaction is less frequent due to his research focus, the impact of his work on patient outcomes is undeniable. His research on the oxygen-sensing pathway has led to the development of new drugs for the treatment of cancer and anemia, improving the lives of countless individuals worldwide. His work on VHL mutations and HIFs have led to targeted therapies for renal cell carcinoma, improving survival rates and quality of life for affected patients.\n\nFurthermore, his research has spurred further investigation into the role of oxygen sensing in other diseases, such as heart disease, stroke, and diabetes. This has opened up new avenues for therapeutic intervention and holds the promise of improving outcomes for patients with these conditions.\n\nAlthough details on specific community work are not widely available, Dr. Kaelin's commitment to advancing medical knowledge and improving patient care extends beyond the laboratory. He is a frequent speaker at scientific conferences and public lectures, sharing his research findings with the broader community and inspiring the next generation of scientists. He also actively participates in outreach programs aimed at promoting science education and increasing public awareness of cancer research.\n\nHe actively advocates for increased funding for scientific research, recognizing that investment in basic science is essential for driving medical progress and improving human health. He also emphasizes the importance of collaboration and open communication among scientists, believing that this is critical for accelerating the pace of discovery.\n\n## 6. Legacy and Future Outlook\n\nDr. William Kaelin Jr. holds an esteemed position within the medical and scientific community. His groundbreaking research on oxygen sensing has revolutionized our understanding of cellular biology and has had a profound impact on the development of new therapies for cancer and other diseases. His Nobel Prize is a testament to the significance of his work and his lasting contribution to medical science.\n\nHis legacy extends beyond his scientific discoveries. He is also recognized as a dedicated mentor and educator, having trained numerous young scientists who are now making their own contributions to the field. His commitment to fostering a collaborative and supportive research environment has helped to create a vibrant and innovative scientific community.\n\nLooking to the future, Dr. Kaelin remains actively engaged in research, continuing to explore the complexities of cancer biology and the potential for new therapeutic interventions. He is particularly interested in understanding the mechanisms by which cancer cells adapt to their environment and the development of strategies to overcome drug resistance. He will likely continue to explore the nuances of HIF regulation and its implications for various diseases, potentially leading to even more targeted and effective therapies.\n\nHis work will undoubtedly continue to inspire and guide future generations of scientists, ensuring that his legacy as a physician-scientist will endure for many years to come. His commitment to rigorous scientific inquiry, combined with his unwavering dedication to improving patient care, serves as an example for all those who aspire to make a difference in the world through medicine and science.\n",
  "bioGenerated": true
}